![]()
|
|
||||||||
(Received for publication, September 18, 1996, and in revised form, December 30, 1996)
From the There are two types of the activin-binding
protein follistatin (FS), FS-288 and FS-315. These result from
alternative splicing of mRNA. FS-288 exhibits high affinity for
cell-surface heparan sulfate proteoglycans, whereas FS-315 shows low
affinity. To understand the physiological role of cell-associated FS,
we investigated the binding of activin to cell-associated FS and its
behavior on the cell surface using primary cultured rat pituitary
cells. Affinity cross-linking experiments using
125I-activin A demonstrated that activin bound to rat
pituitary cells via FS as well as to their receptors on the cell
surface. FS-288 promoted the binding of activin A to the cell surface
more markedly than FS-315. When the cells were incubated with
125I-activin A in the presence of FS-288, significant
degradation of activin A was observed, and this was dependent on the
FS-288 concentration. This activin degradation was abolished by heparan sulfate, chloroquine, and several lysosomal enzyme inhibitors. Moreover, FS-288 stimulated cellular uptake of activin A, whereas chloroquine suppressed lysosomal degradation following internalization, as demonstrated by microscopic autoradiography. These results suggest
that cell-associated FS-288 accelerates the uptake of activin A into
pituitary cells, leading to increased degradation by lysosomal enzymes,
and thus plays a role in the activin clearance system.
Volume 272, Number 21,
Issue of May 23, 1997
pp. 13835-13842
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
ENDOCYTOTIC DEGRADATION OF ACTIVIN AND ITS ACCELERATION BY
FOLLISTATIN ASSOCIATED WITH CELL-SURFACE HEPARAN SULFATE
§
,
,
,
Institute for Enzyme Research, University of
Tokushima, Kuramoto, Tokushima 770, Japan, the
§ Department of Veterinary Anatomy, Faculty of Agriculture,
University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113, Japan, and
¶ Department of Reproductive Medicine, School of Medicine,
University of California,
San Diego, La Jolla, California 92093-0674
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
B. Barakat, A. E O'Connor, E. Gold, D. M de Kretser, and K. L Loveland Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice Reproduction, September 1, 2008; 136(3): 345 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Lin, R. G. Craythorn, A. E. O'Connor, M. M. Matzuk, J. E. Girling, J. R. Morrison, and D. M. de Kretser Female Infertility and Disrupted Angiogenesis Are Actions of Specific Follistatin Isoforms Mol. Endocrinol., February 1, 2008; 22(2): 415 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Lerch, S. Shimasaki, T. K. Woodruff, and T. S. Jardetzky Structural and Biophysical Coupling of Heparin and Activin Binding to Follistatin Isoform Functions J. Biol. Chem., May 25, 2007; 282(21): 15930 - 15939. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sidis, A. Mukherjee, H. Keutmann, A. Delbaere, M. Sadatsuki, and A. Schneyer Biological Activity of Follistatin Isoforms and Follistatin-Like-3 Is Dependent on Differential Cell Surface Binding and Specificity for Activin, Myostatin, and Bone Morphogenetic Proteins Endocrinology, July 1, 2006; 147(7): 3586 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Harrison, K. L. Chan, and D. M. Robertson Activin-A Binds Follistatin and Type II Receptors through Overlapping Binding Sites: Generation of Mutants with Isolated Binding Activities Endocrinology, June 1, 2006; 147(6): 2744 - 2753. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Glister, N. P Groome, and P. G Knight Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid J. Endocrinol., February 1, 2006; 188(2): 215 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aoki, M. Kurabayashi, Y. Hasegawa, and I. Kojima Attenuation of Bleomycin-induced Pulmonary Fibrosis by Follistatin Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 713 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sidis, A. L. Schneyer, and H. T. Keutmann Heparin and Activin-Binding Determinants in Follistatin and FSTL3 Endocrinology, January 1, 2005; 146(1): 130 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jasuja, B. L. Allen, W. N. Pappano, A. C. Rapraeger, and D. S. Greenspan Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin J. Biol. Chem., December 3, 2004; 279(49): 51289 - 51297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Wu, P. Su, N. W. Safwat, J. Sebastian, and W. L. Miller Rapid, Efficient Isolation of Murine Gonadotropes and Their Use in Revealing Control of Follicle-Stimulating Hormone by Paracrine Pituitary Factors Endocrinology, December 1, 2004; 145(12): 5832 - 5839. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Degnin, F. Jean, G. Thomas, and J. L. Christian Cleavages within the Prodomain Direct Intracellular Trafficking and Degradation of Mature Bone Morphogenetic Protein-4 Mol. Biol. Cell, November 1, 2004; 15(11): 5012 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamashita, A. Maeshima, I. Kojima, and Y. Nojima Activin A Is a Potent Activator of Renal Interstitial Fibroblasts J. Am. Soc. Nephrol., January 1, 2004; 15(1): 91 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Tannetta, S. Muttukrishna, N. P. Groome, C. W. G. Redman, and I. L. Sargent Endothelial Cells and Peripheral Blood Mononuclear Cells Are a Potential Source of Extraplacental Activin A in Preeclampsia J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5995 - 6001. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Innis and M. Hyvonen Crystal Structures of the Heparan Sulfate-binding Domain of Follistatin: INSIGHTS INTO LIGAND BINDING J. Biol. Chem., October 10, 2003; 278(41): 39969 - 39977. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Arai, K. Tsuchida, K. Uehara, K. Taya, and H. Sugino Characterization of Rat Follistatin-Related Gene: Effects of Estrous Cycle Stage and Pregnancy on Its Messenger RNA Expression in Rat Reproductive Tissues Biol Reprod, January 1, 2003; 68(1): 199 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Standal, C. Seidel, O. Hjertner, T. Plesner, R. D. Sanderson, A. Waage, M. Borset, and A. Sundan Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells Blood, September 26, 2002; 100(8): 3002 - 3007. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sidis, D. V. Tortoriello, W. E. Holmes, Y. Pan, H. T. Keutmann, and A. L. Schneyer Follistatin-Related Protein and Follistatin Differentially Neutralize Endogenous vs. Exogenous Activin Endocrinology, May 1, 2002; 143(5): 1613 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Padmanabhan, D. Battaglia, M. B. Brown, F. J. Karsch, J. S. Lee, W. Pan, D. J. Phillips, and J. Van Cleeff Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion: II. Is Follistatin-Induced Suppression of FSH Secretion Mediated via Changes in Activin Availability and Does It Involve Changes in Gonadotropin-Releasing Hormone Secretion? Biol Reprod, May 1, 2002; 66(5): 1395 - 1402. [Abstract] [Full Text] |
||||
![]() |
R. L. Jones, L. A. Salamonsen, Y. C. Zhao, J.-F. Ethier, A. E. Drummond, and J. K. Findlay Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization Mol. Hum. Reprod., April 1, 2002; 8(4): 363 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujiwara, Y. Sidis, C. Welt, G. Lambert-Messerlian, J. Fox, A. Taylor, and A. Schneyer Dynamics of Inhibin Subunit and Follistatin mRNA during Development of Normal and Polycystic Ovary Syndrome Follicles J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4206 - 4215. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Tortoriello, Y. Sidis, D. A. Holtzman, W. E. Holmes, and A. L. Schneyer Human Follistatin-Related Protein: A Structural Homologue of Follistatin with Nuclear Localization Endocrinology, August 1, 2001; 142(8): 3426 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MAESHIMA, Y.-Q. ZHANG, Y. NOJIMA, T. NARUSE, and I. KOJIMA Involvement of the Activin-Follistatin System in Tubular Regeneration after Renal Ischemia in Rats J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1685 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Winters, S. Kawakami, A. Sahu, and T. M. Plant Pituitary Follistatin and Activin Gene Expression, and the Testicular Regulation of FSH in the Adult Rhesus Monkey (Macaca mulatta) Endocrinology, July 1, 2001; 142(7): 2874 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Huang, J. C. Wu, P. Su, O. Zhirnov, and W. L. Miller A Novel Role for Bone Morphogenetic Proteins in the Synthesis of Follicle-Stimulating Hormone Endocrinology, June 1, 2001; 142(6): 2275 - 2283. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Keith Ho, K. E. McGrath, K. C. Brodbeck, J. Palis, and B. P. Schick Serglycin Proteoglycan Synthesis in the Murine Uterine Decidua and Early Embryo Biol Reprod, June 1, 2001; 64(6): 1667 - 1676. [Abstract] [Full Text] |
||||
![]() |
Q. Wang, H. T. Keutmann, A. L. Schneyer, and P. M. Sluss Analysis of Human Follistatin Structure: Identification of Two Discontinuous N-Terminal Sequences Coding for Activin A Binding and Structural Consequences of Activin Binding to Native Proteins Endocrinology, September 1, 2000; 141(9): 3183 - 3193. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Phillips, K. L. Jones, D. J. McGaw, N. P. Groome, J. J. Smolich, H. Pärsson, and D. M. de Kretser Release of Activin and Follistatin during Cardiovascular Procedures Is Largely due to Heparin Administration J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2411 - 2415. [Abstract] [Full Text] |
||||
![]() |
W.X. Liao, A.C. Roy, and S.C. Ng Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome Mol. Hum. Reprod., July 1, 2000; 6(7): 587 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ni, S. Luo, T. Minegishi, and C. Peng Activin A in JEG-3 Cells: Potential Role as an Autocrine Regulator of Steroidogenesis in Humans Biol Reprod, May 1, 2000; 62(5): 1224 - 1230. [Abstract] [Full Text] |
||||
![]() |
D. C. Danila, W. J. Inder, X. Zhang, J. M. Alexander, B. Swearingen, E. T. Hedley-Whyte, and A. Klibanski Activin Effects on Neoplastic Proliferation of Human Pituitary Tumors J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1009 - 1015. [Abstract] [Full Text] |
||||
![]() |
H. Shoji, K. Tsuchida, H. Kishi, N. Yamakawa, T. Matsuzaki, Z. Liu, T. Nakamura, and H. Sugino Identification and Characterization of a PDZ Protein That Interacts with Activin Type II Receptors J. Biol. Chem., February 25, 2000; 275(8): 5485 - 5492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Gardner, J. Sebastian, and W. L. Miller Estradiol Induces and Hyperglycosylates the Receptor for Ovine Gonadotropin-Releasing Hormone Endocrinology, January 1, 2000; 141(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takabe, J.-J. Lebrun, Y. Nagashima, Y. Ichikawa, M. Mitsuhashi, N. Momiyama, T. Ishikawa, H. Shimada, and W. W. Vale Interruption of Activin A Autocrine Regulation by Antisense Oligodeoxynucleotides Accelerates Liver Tumor Cell Proliferation Endocrinology, July 1, 1999; 140(7): 3125 - 3132. [Abstract] [Full Text] |
||||
![]() |
A. Delbaere, Y. Sidis, and A. L. Schneyer Differential Response to Exogenous and Endogenous Activin in a Human Ovarian Teratocarcinoma-Derived Cell Line (PA-1): Regulation by Cell Surface Follistatin Endocrinology, June 1, 1999; 140(6): 2463 - 2470. [Abstract] [Full Text] |
||||
![]() |
A.E. O'Connor, J.R. McFarlane, S. Hayward, T. Yohkaichiya, N.P. Groome, and D.M. de Kretser Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study Hum. Reprod., March 1, 1999; 14(3): 827 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamane, R. Tohno-oka, S. Yamada, S. Furuya, K. Shiokawa, Y. Hirabayashi, H. Sugino, and K. Sugahara Molecular Characterization of Xenopus Embryo Heparan Sulfate. DIFFERENTIAL STRUCTURAL REQUIREMENTS FOR THE SPECIFIC BINDING TO BASIC FIBROBLAST GROWTH FACTOR AND FOLLISTATIN J. Biol. Chem., March 27, 1998; 273(13): 7375 - 7381. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuchida, K. Y. Arai, Y. Kuramoto, N. Yamakawa, Y. Hasegawa, and H. Sugino Identification and Characterization of a Novel Follistatin-like Protein as a Binding Protein for the TGF-beta Family J. Biol. Chem., December 22, 2000; 275(52): 40788 - 40796. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sidis, A. L. Schneyer, P. M. Sluss, L. N. Johnson, and H. T. Keutmann Follistatin: Essential Role for the N-terminal Domain in Activin Binding and Neutralization J. Biol. Chem., May 18, 2001; 276(21): 17718 - 17726. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paine-Saunders, B. L. Viviano, A. N. Economides, and S. Saunders Heparan Sulfate Proteoglycans Retain Noggin at the Cell Surface. A POTENTIAL MECHANISM FOR SHAPING BONE MORPHOGENETIC PROTEIN GRADIENTS J. Biol. Chem., January 11, 2002; 277(3): 2089 - 2096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |